Menstrual spotting
|
phenotype |
|
Sign or Symptom
|
27
|
2
|
0.030 |
None |
1.000 |
3 |
|
1993 |
1996 |
Cachexia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
273
|
11
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2016 |
CUI: |
C0015967 |
Disease: |
Fever
|
Fever
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1021
|
66
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
eyelids (symptom)
|
phenotype |
|
Sign or Symptom
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Anoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
287
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
1991 |
1991 |
Hyperpigmentation
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
73
|
11
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Progressive hyperpigmentation
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Hair Color
|
phenotype |
|
Organism Attribute
|
130
|
312
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
19 |
|
1991 |
2019 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
0.875 |
16 |
|
1991 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
14 |
|
2008 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
12 |
|
1992 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
10 |
|
2009 |
2019 |
Testicular Germ Cell Tumor
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
208
|
93
|
0.150 |
None |
1.000 |
9 |
2
|
2008 |
2017 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.080 |
None |
1.000 |
8 |
|
1992 |
2013 |
Testicular Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
124
|
31
|
0.410 |
None |
1.000 |
6 |
3
|
2009 |
2013 |
Malignant neoplasm of testis
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
253
|
31
|
0.430 |
None |
1.000 |
6 |
7
|
1994 |
2012 |
Gastrointestinal Stromal Tumors
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
538
|
154
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2017 |
Malignant Testicular Germ Cell Tumor
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
128
|
62
|
0.150 |
None |
1.000 |
6 |
8
|
1994 |
2012 |
Germ cell tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
278
|
5
|
0.330 |
None |
1.000 |
5 |
|
2009 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.040 |
None |
1.000 |
4 |
1
|
1999 |
2014 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.040 |
None |
1.000 |
4 |
|
1992 |
2017 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2015 |